ArticleInternational journal of clinical oncology2008

Clinical outcome and prognostic survival factors in patients with advanced renal cell carcinoma treated with very low-dose interleukin-2, interferon-alpha, and tegafur-uracil: a single-institution experience.

Minoru Kobayashi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.